Brainomix raises €5.5M Bridge round
24 February 2026· Oxford, United Kingdom· health, medical_imaging, ai, b2b, b2g, pure_software
The funding extension will accelerate the company's US rollout of its AI-powered imaging platforms for stroke and lung fibrosis and enhance customer support
“Stroke care depends on speed, while lung fibrosis care requires early identification and consistent clinical decision-making over time, underscoring the need for hospital technologies that support clinicians at the point of care. With this investment extension, we are well-positioned to enhance customer support across the US and Europe, accelerating the seamless integration of our technology into existing clinical workflows and expanding access to life-saving treatments.”
Investors
LeadParkwalk Advisors
Also participating
Modi VenturesHostplus
About Brainomix
Headquarters
Oxford, United Kingdom
Founded
2010
Team Size
51–200
Sectors
healthmedical_imagingaib2bb2gpure_software